{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:14:15Z","timestamp":1770488055469,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10096-020-04000-9","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:25:41Z","timestamp":1596068741000},"page":"219-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6455-9848","authenticated-orcid":false,"given":"Irene","family":"Galani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2226-0239","authenticated-orcid":false,"given":"Ilias","family":"Karaiskos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evdokia","family":"Angelidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Papoutsaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamprini","family":"Galani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-4534","authenticated-orcid":false,"given":"Maria","family":"Souli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-9198","authenticated-orcid":false,"given":"Anastasia","family":"Antoniadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7387-5065","authenticated-orcid":false,"given":"Helen","family":"Giamarellou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"4000_CR1","doi-asserted-by":"publisher","first-page":"1700775","DOI":"10.2807\/1560-7917.ES.2018.23.30.1700775","volume":"23","author":"I Galani","year":"2018","unstructured":"Galani I, Karaiskos I, Karantani I, Papoutsaki V, Maraki S, Papaioannou V, Kazila P, Tsorlini H, Charalampaki N, Toutouza M, Vagiakou H, Pappas K, Kyratsa A, Kontopoulou K, Legga O, Petinaki E, Papadogeorgaki H, Chinou E, Souli M, Giamarellou H, On Behalf of The Study Collaborators (2018) Epidemiology and resistance phenotypes of carbapenemase producing Klebsiella pneumoniae in Greece, 2014 to 2016. Euro Surveill 23:1700775. https:\/\/doi.org\/10.2807\/1560-7917.ES.2018.23.30.1700775","journal-title":"Euro Surveill"},{"key":"4000_CR2","doi-asserted-by":"publisher","first-page":"e02097","DOI":"10.1128\/AAC.02097-16","volume":"61","author":"RK Shields","year":"2017","unstructured":"Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJ (2017) Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of Carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother 61:e02097\u2013e02016. https:\/\/doi.org\/10.1128\/AAC.02097-16","journal-title":"Antimicrob Agents Chemother"},{"key":"4000_CR3","unstructured":"European Centre for Disease Prevention and Control (2018) Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae \u2013 12 June 2018. Stockholm; Available from: https:\/\/ecdc.europa.eu\/en\/publications-data\/rapid-risk-assessmentemergenceresistance-ceftazidime-avibactam-carbapenem"},{"key":"4000_CR4","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2020). Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0. Vaxjo: EUCAST; Available from; http:\/\/www.eucast.org"},{"key":"4000_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"4000_CR6","doi-asserted-by":"publisher","unstructured":"Zhu Y, Galani I, Karaiskos I, Lu J, Aye SM, Huang J, Yu HH, Velkov T, Giamarellou H, Li J (2019) Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment. J Infect 79:312\u2013321. https:\/\/doi.org\/10.1016\/j.jinf.2019.07.009","DOI":"10.1016\/j.jinf.2019.07.009"},{"key":"4000_CR7","doi-asserted-by":"publisher","first-page":"e02101","DOI":"10.1128\/AAC.02101-17","volume":"62","author":"MJ Giddins","year":"2018","unstructured":"Giddins MJ, Macesic N, Annavajhala MK, Stump S, Khan S, McConville TH, Mehta M, Gomez-Simmonds A, Uhlemann AC (2018) Successive emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in blaKPC-2-harboring Klebsiella pneumoniae sequence type 307 isolates. Antimicrob Agents Chemother 62:e02101\u2013e02117. https:\/\/doi.org\/10.1128\/AAC.02101-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4000_CR8","doi-asserted-by":"publisher","first-page":"e01940","DOI":"10.1128\/AAC.01940-19","volume":"64","author":"H Volland","year":"2019","unstructured":"Volland H, Girlich D, Laguide M, Gonzalez C, Paris V, Laroche M, Oueslati S, Dortet L, Simon S, Naas T (2019) Improvement of the Immunochromatographic NG-test Carba 5 assay for the detection of IMP variants previously undetected. Antimicrob Agents Chemother 64(1):e01940\u2013e01919. https:\/\/doi.org\/10.1128\/AAC.01940-19","journal-title":"Antimicrob Agents Chemother"},{"key":"4000_CR9","doi-asserted-by":"publisher","first-page":"1900256","DOI":"10.2807\/1560-7917.ES.2019.24.19.1900256","volume":"24","author":"K R\u00e4is\u00e4nen","year":"2019","unstructured":"R\u00e4is\u00e4nen K, Koivula I, Ilmavirta H, Puranen S, Kallonen T, Lyytik\u00e4inen O, Jalava J (2019) Emergence of ceftazidime-avibactam-resistant Klebsiella pneumoniae during treatment, Finland, December 2018. Euro Surveill 24:1900256. https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.19.1900256","journal-title":"Euro Surveill"},{"key":"4000_CR10","doi-asserted-by":"publisher","first-page":"763.e5-8","DOI":"10.1016\/j.cmi.2019.03.011","volume":"25","author":"I Galani","year":"2019","unstructured":"Galani I, Antoniadou A, Karaiskos I, Kontopoulou K, Giamarellou H, Souli M (2019) Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam. Clin Microbiol Infect 25:763.e5-8. https:\/\/doi.org\/10.1016\/j.cmi.2019.03.011","journal-title":"Clin Microbiol Infect"},{"key":"4000_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1099\/jmm.0.000397","volume":"66","author":"A Margaritis","year":"2017","unstructured":"Margaritis A, Galani I, Chatzikonstantinou M, Petrikkos G, Souli M (2017) Plasmid-mediated quinolone resistance determinants among gram-negative bacteraemia isolates: a hidden threat. J Med Microbiol 66:266\u2013275. https:\/\/doi.org\/10.1099\/jmm.0.000397","journal-title":"J Med Microbiol"},{"key":"4000_CR12","doi-asserted-by":"publisher","first-page":"2000028","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000028","volume":"25","author":"I Galani","year":"2020","unstructured":"Galani I, Karaiskos I, Souli M, Papoutsaki V, Galani L, Gkoufa A, Antoniadou A, Giamarellou H (2020) Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019. Euro Surveill 25:2000028. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.3.2000028","journal-title":"Euro Surveill"},{"key":"4000_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jgar.2019.07.027","volume":"20","author":"G Meletis","year":"2020","unstructured":"Meletis G, Chatzopoulou F, Fragkouli A, Alexandridou M, Mavrovouniotis I, Chatzinikolaou A, Chatzidimitriou D (2020) Whole-genome sequencing study of KPC-encoding Klebsiella pneumoniae isolated in Greek private laboratories from non-hospitalised patients. J Glob Antimicrob Resist 20:78\u201381. https:\/\/doi.org\/10.1016\/j.jgar.2019.07.027","journal-title":"J Glob Antimicrob Resist"},{"key":"4000_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1089\/mdr.2013.0193","volume":"20","author":"Z Belbel","year":"2014","unstructured":"Belbel Z, Chettibi DM, Ladjama A, Nedjai S, Rolain JM (2014) Outbreak of an armA methyltransferase-producing ST39 Klebsiella pneumoniae clone in a pediatric Algerian hospital. Microb Drug Resist 20:310\u2013315. https:\/\/doi.org\/10.1089\/mdr.2013.0193","journal-title":"Microb Drug Resist"},{"key":"4000_CR15","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.3389\/fmicb.2019.02817","volume":"10","author":"RE Weber","year":"2019","unstructured":"Weber RE, Pietsch M, Fr\u00fchauf A, Pfeifer Y, Martin M, Luft D, Gatermann S, Pfennigwerth N, Kaase M, Werner G, Fuchs S (2019) IS26-mediated transfer of bla (NDM-1) as the main route of resistance transmission during a polyclonal, multispecies outbreak in a German hospital. Front Microbiol 10:2817. https:\/\/doi.org\/10.3389\/fmicb.2019.02817","journal-title":"Front Microbiol"},{"key":"4000_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/ijmm.IJMM_16_381","volume":"35","author":"H Liu","year":"2017","unstructured":"Liu H, Wilksch J, Li B, Du J, Cao J, Zhang X, Zhou T (2017) Emergence of ST39 and ST656 extensively drug-resistant Klebsiella pneumoniae isolates in Wenzhou, China. Indian J Med Microbiol 35:145\u2013146. https:\/\/doi.org\/10.4103\/ijmm.IJMM_16_381","journal-title":"Indian J Med Microbiol"},{"key":"4000_CR17","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1128\/JCM.00020-12","volume":"50","author":"D Gij\u00f3n","year":"2012","unstructured":"Gij\u00f3n D, Curiao T, Baquero F, Coque TM, Cant\u00f3n R (2012) Fecal carriage of carbapenemase producing Enterobacteriaceae: a hidden reservoir in hospitalized and non hospitalized patients. J Clin Microbiol 50:1558\u20131563. https:\/\/doi.org\/10.1128\/JCM.00020-12","journal-title":"J Clin Microbiol"},{"key":"4000_CR18","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1128\/JCM.01049-13","volume":"51","author":"A Adler","year":"2013","unstructured":"Adler A, Solter E, Masarwa S, Miller-Roll T, Abu-Libdeh B, Khammash H, Najem K, Dekadek S, Stein-Zamir C, Nubani N, Kunbar A, Assous MV, Carmeli Y, Schwaber MJ (2013) Epidemiological and microbiological characteristics of an outbreak caused by OXA-48-producing Enterobacteriaceae in a neonatal intensive care unit in Jerusalem, Israel. J Clin Microbiol 51:2926\u20132930. https:\/\/doi.org\/10.1128\/JCM.01049-13","journal-title":"J Clin Microbiol"},{"key":"4000_CR19","doi-asserted-by":"publisher","first-page":"e00537","DOI":"10.1128\/AAC.00537-17","volume":"61","author":"RM Humphries","year":"2017","unstructured":"Humphries RM, Hemarajata P (2017) Resistance to ceftazidime-avibactam in Klebsiella pneumoniae due to porin mutations and the increased expression of KPC-3. Antimicrob Agents Chemother 61:e00537\u2013e00517. https:\/\/doi.org\/10.1128\/AAC.00537-17","journal-title":"Antimicrob Agents Chemother"},{"key":"4000_CR20","doi-asserted-by":"publisher","first-page":"e00989","DOI":"10.1128\/AAC.00989-17","volume":"61","author":"K Nelson","year":"2017","unstructured":"Nelson K, Hemarajata P, Sun D, Rubio-Aparicio D, Tsivkovski R, Yang S, Sebra R, Kasarskis A, Nguyen H, Hanson BM, Leopold S, Weinstock G, Lomovskaya O, Humphries RM (2017) Resistance to ceftazidime-avibactam is due to transposition of KPC in a porin-deficient strain of Klebsiella pneumoniae with increased efflux activity. Antimicrob Agents Chemother 61:e00989\u2013e00917. https:\/\/doi.org\/10.1128\/AAC.00989-17","journal-title":"Antimicrob Agents Chemother"},{"key":"4000_CR21","doi-asserted-by":"publisher","first-page":"516.e1","DOI":"10.1016\/j.cmi.2019.11.011","volume":"26","author":"P Gaibani","year":"2019","unstructured":"Gaibani P, Carla Re M, Campoli C, Viale P, Ambretti S (2019) Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime\/avibactam: epidemiology and genomic characterization. Clin Microbiol Infect 26:516.e1\u2013516.e4. https:\/\/doi.org\/10.1016\/j.cmi.2019.11.011","journal-title":"Clin Microbiol Infect"},{"key":"4000_CR22","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/jac\/dkz201","volume":"74","author":"C Venditti","year":"2019","unstructured":"Venditti C, Nisii C, Ballardini M, Meledandri M, Di Caro A (2019) Identification of L169P mutation in the omega loop of KPC-3 after a short course of ceftazidime\/avibactam. J Antimicrob Chemother 74:2466\u20132467. https:\/\/doi.org\/10.1093\/jac\/dkz201","journal-title":"J Antimicrob Chemother"},{"key":"4000_CR23","doi-asserted-by":"publisher","first-page":"114954","DOI":"10.1016\/j.diagmicrobio.2019.114954","volume":"96","author":"KM Squires","year":"2020","unstructured":"Squires KM, Nguyen MH, Shields RK, Clancy CJ (2020) Sequence type-258 carbapenem-resistant Klebsiella pneumoniae isolates in which ceftazidime-avibactam resistance emerged are not hypermutators. Diagn Microbiol Infect Dis 96:114954. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.114954","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04000-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-04000-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04000-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T23:43:45Z","timestamp":1627602225000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-04000-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4000"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-04000-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Written informed consent was obtained from all patients or legal representatives and the study was performed in accordance with good clinical practice guidelines. The study protocol was approved by the Ethics Committee of Hygeia General Hospital [registration no. 627\/26-09-2018].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}